Book Value Bawat Bahagi: Sage Therapeutics, Inc (SAGE)

Sage Therapeutics, Inc. (SAGE) - korporatibong logo

Ang book value per share ng Sage Therapeutics, Inc. (SAGE) ay nagpapakita ng tunay na capital resilience, kung saan ang 5.93 metric ang nagtatakda ng antas na ito. Ang pamunuan ay nagtataglay ng malalim na kadalubhasaan sa neuroscience at tinitiyak ang transparency sa lahat ng yugto ng pananaliksik. Ang US manufacturer ay nakatuon sa therapy ng mga depressive states, na umaasa sa suporta mula sa Biogen. Ang kasalukuyang tagumpay ay nakabase sa implementasyon ng Zurzuvae, sa kabila ng pagbabawas ng ilang mga programa para sa Alzheimer's.

Stockholders Equity Bawat Bahagi Sage Therapeutics Inc. (SAGE): para sa panahong 04.07.2022 - 16.08.2025

sagerx.com - mga analytical breakdown at pangunahing sukatan (SAGE)

- presyo at pagtataya ng pinagkasunduang presyo:
Presyo ng Stock Sage Therapeutics, Inc|SAGE - Saklaw ng Target ng Analyst
- datos sa market capitalization:
Kapitalisasyon sa Merkado Sage Therapeutics, Inc.|SAGE - Kabuuang Halaga ng Negosyo
- datos sa book capitalization:
Netong Asset Bawat Isang Bahagi Sage Therapeutics|SAGE - Accounting Capitalization|Ratio ng Market Capitalization sa Book Value sagerx.com|SAGE - Mga Asset ng Kumpanya
- datos sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Sage Therapeutics, Inc.|SAGE - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Sage Therapeutics|SAGE - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Sage Therapeutics, Inc.|SAGE - Pangmatagalang utang|Panandaliang utang ng kumpanya Sage Therapeutics
Fundamental valuation ng kumpanya:Sage Therapeutics, Inc, SAGE
Mga produktong ginagawa ng Sage Therapeutics

Ang isang investment audit ng Sage Therapeutics, Inc. (SAGE) ay nangangailangan ng isang pagsusuri ng book value per share, na kinakalkula bilang pagkakaiba sa pagitan ng kabuuang assets at liabilities na hinati sa bilang ng shares outstanding. Sa gitna ng biotech portfolio optimization at pagdepende sa mga benta ng bagong produkto, ang target book value per share ay nagsisilbing isang indicator ng aktwal na capital preservation, hindi kabilang ang market volatility.

Pagsusuri ng mga kakumpitensya ng Sage Therapeutics, Inc.

Book Value Bawat Bahagi BIIB|NBIX - Book Value ng Isang Bahagi|Book Value Bawat Bahagi RGC|AXSM (axsome.com) - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc. (ACAD)|Stockholders Equity Bawat Bahagi Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Supernus Corp SUPN|Accounting Book Value Bawat Bahagi CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi AMLX|TRVI (Trevi Corp) - Net Asset Value Bawat Bahagi|PRAX: Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi anavex.com|Book Value Bawat Bahagi CBLL|Book Value Bawat Bahagi Prothena Corporation (PRTA)|ALEC (Alector) - Book Value Bawat Bahagi|Book Value ng Isang Bahagi Annexon Biosciences Inc. ANNX|OMER (Omeros Corp.) - Book Value Bawat Bahagi|neurogene.com (NGNE) - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi AC Immune SA ACIU|Accounting Value ng Bahagi Voyager Therapeutics Inc|Neumora Therapeutics Inc (NMRA) - Accounting Book Value Bawat Bahagi|Book Price ng Bahagi Scilex Holding Company, Inc.|Tevogen Bio Holdings (TVGN) - Book Value Bawat Bahagi|Accounting Value ng Bahagi alphacognition.com (ACOG)|CGTX: Book Value Bawat Bahagi|Inhibikase Therapeutics Inc - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Cassava (SAVA)|ASRT - Accounting Value ng Bahagi|COYA: Book Value Bawat Bahagi|VTGN (Vistagen) - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Ovid Therapeutics Inc OVID|Book Value ng Bahagi Acumen Pharmaceuticals Inc.|CervoMed Inc - Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi alteritytherapeutics.com ATHE|Accounting Book Value Bawat Bahagi CLNN (Clene)|PEPG - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi Jupiter Neurosciences Inc JUNS|RLMD - Book Price ng Bahagi|Annovis Bio Corp - Book Value Bawat Bahagi|Grace Therapeutics (GRCE) - Net Assets Bawat Bahagi|Book Value Bawat Bahagi AIFF|Accounting Book Value Bawat Bahagi KLTO|NRSN (NeuroSense Therapeutics) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Book Value Bawat Bahagi MetaVia|Accounting Value ng Bahagi NeurAxis Inc NRXS|Book Value Bawat Bahagi HSDT (Helius Medical Technologies Inc.)|PASG: Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi bionomics.com.au|Minerva Neurosciences Inc (NERV) - Stockholders Equity Bawat Bahagi|Book Value Bawat Bahagi ATHA|Accounting Book Value Bawat Bahagi Addex (ADXN)|ALZN (Alzamend Neuro, Inc.) - Accounting Book Value Bawat Bahagi|Net Assets Bawat Bahagi CYCN (cyclerion.com)|Netong Asset Bawat Isang Bahagi PTIX|Net Assets Bawat Bahagi Pasithea Therapeutics Corp KTTA|Cortigent Medical - Book Value Bawat Bahagi|ATXI - Book Value Bawat Bahagi|Book Value Bawat Bahagi BCLI (Brainstorm Cell)|caratherapeutics.com (CARA) - Book Value ng Isang Bahagi|Book Value Bawat Bahagi CHRO (Chromocell Therapeutics Corp.)|Net Asset Value Bawat Bahagi ELYM|Netong Asset Bawat Isang Bahagi Intra-Cellular Therapies ITCI|Stockholders Equity Bawat Bahagi Longboard (LBPH)|MRNS: Book Value Bawat Bahagi|NKGN - Net Asset Value Bawat Bahagi|NeuroBo Pharmaceuticals, Inc. - Accounting Book Value Bawat Bahagi|SNPX: Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Trevena, Inc TRVN|VIGL (Vigil Neuroscience, Inc.) - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi WENA (Anew Medical)|Net Asset Value Bawat Bahagi CERE